Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical and diagnostic relevance of NOTCH2-and KLF2-mutations in splenic marginal zone lymphoma.
Campos-Martín Y, Martínez N, Martínez-López A, Cereceda L, Casado F, Algara P, Oscier D, Menarguez FJ, García JF, Piris MA, Mollejo M. Campos-Martín Y, et al. Among authors: cereceda l. Haematologica. 2017 Aug;102(8):e310-e312. doi: 10.3324/haematol.2016.161711. Epub 2017 May 18. Haematologica. 2017. PMID: 28522570 Free PMC article. No abstract available.
NFκB expression is a feature of both activated B-cell-like and germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Odqvist L, Montes-Moreno S, Sánchez-Pacheco RE, Young KH, Martín-Sánchez E, Cereceda L, Sánchez-Verde L, Pajares R, Mollejo M, Fresno MF, Mazorra F, Ruíz-Marcellán C, Sánchez-Beato M, Piris MA. Odqvist L, et al. Among authors: cereceda l. Mod Pathol. 2014 Oct;27(10):1331-7. doi: 10.1038/modpathol.2014.34. Epub 2014 Mar 7. Mod Pathol. 2014. PMID: 24603590 Free article.
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis.
Montes-Moreno S, Batlle A, de Villambrosía SG, Sánchez-Espiridión B, Cereceda L, González-Barca E, Purroy N, Pardal E, Martín A, Grande C, Mazorra F, Insunza A, Quero C, Aguiar D, Cruz MA, Rueda A, Llanos M, Codina JG, Arroyo FR, Caballero D, Conde E, López A, Provencio M, Piris M. Montes-Moreno S, et al. Among authors: cereceda l. Haematologica. 2014 Aug;99(8):e138-41. doi: 10.3324/haematol.2014.104976. Epub 2014 Apr 24. Haematologica. 2014. PMID: 24763400 Free PMC article. Clinical Trial. No abstract available.
The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature.
Manso R, Sánchez-Beato M, Monsalvo S, Gómez S, Cereceda L, Llamas P, Rojo F, Mollejo M, Menárguez J, Alves J, García-Cosio M, Piris MA, Rodríguez-Pinilla SM. Manso R, et al. Among authors: cereceda l. Blood. 2014 May 1;123(18):2893-4. doi: 10.1182/blood-2014-02-555946. Blood. 2014. PMID: 24786457 Free article. No abstract available.
Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas.
Manso R, Rodríguez-Pinilla SM, González-Rincón J, Gómez S, Monsalvo S, Llamas P, Rojo F, Pérez-Callejo D, Cereceda L, Limeres MA, Maeso C, Ferrando L, Pérez-Seoane C, Rodríguez G, Arrinda JM, García-Bragado F, Franco R, Rodriguez-Peralto JL, González-Carreró J, Martín-Dávila F, Piris MA, Sánchez-Beato M. Manso R, et al. Among authors: cereceda l. Haematologica. 2015 Jan;100(1):e25-7. doi: 10.3324/haematol.2014.113696. Epub 2014 Oct 10. Haematologica. 2015. PMID: 25304611 Free PMC article. No abstract available.
Chronic lymphocytic leukemia cells in lymph nodes show frequent NOTCH1 activation.
Onaindia A, Gómez S, Piris-Villaespesa M, Martínez-Laperche C, Cereceda L, Montes-Moreno S, Batlle A, de Villambrosia SG, Pollán M, Martín-Acosta P, González-Rincón J, Menarguez J, Alvés J, Rodriguez-Pinilla SM, García JF, Mollejo M, Fraga M, García-Marco JA, Piris MA, Sánchez-Beato M. Onaindia A, et al. Among authors: cereceda l. Haematologica. 2015 May;100(5):e200-3. doi: 10.3324/haematol.2014.117705. Epub 2014 Dec 31. Haematologica. 2015. PMID: 25552700 Free PMC article. No abstract available.
MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A, Curiel-Olmo S, Mollejo M, Cereceda L, Martinez N, Montes-Moreno S, Almaraz C, Revert JB, Piris MA. Martinez-Lopez A, et al. Among authors: cereceda l. Am J Surg Pathol. 2015 May;39(5):644-51. doi: 10.1097/PAS.0000000000000411. Am J Surg Pathol. 2015. PMID: 25723115
Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
Pérez C, González-Rincón J, Onaindia A, Almaráz C, García-Díaz N, Pisonero H, Curiel-Olmo S, Gómez S, Cereceda L, Madureira R, Hospital M, Suárez-Massa D, Rodriguez-Peralto JL, Postigo C, Leon-Castillo A, González-Vela C, Martinez N, Ortiz-Romero P, Sánchez-Beato M, Piris MÁ, Vaqué JP. Pérez C, et al. Among authors: cereceda l. Haematologica. 2015 Nov;100(11):e450-3. doi: 10.3324/haematol.2015.132837. Epub 2015 Aug 20. Haematologica. 2015. PMID: 26294736 Free PMC article. No abstract available.
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.
Curiel-Olmo S, García-Castaño A, Vidal R, Pisonero H, Varela I, León-Castillo A, Trillo E, González-Vela C, García-Diaz N, Almaraz C, Moreno T, Cereceda L, Madureira R, Martinez N, Ortiz-Romero P, Valdizán E, Piris MA, Vaqué JP. Curiel-Olmo S, et al. Among authors: cereceda l. Oncotarget. 2015 Sep 22;6(28):25452-65. doi: 10.18632/oncotarget.4545. Oncotarget. 2015. PMID: 26327537 Free PMC article.
CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
Onaindia A, Martínez N, Montes-Moreno S, Almaraz C, Rodríguez-Pinilla SM, Cereceda L, Revert JB, Ortega C, Tardio A, González L, García S, Camacho FI, González-Vela C, Piris MA. Onaindia A, et al. Among authors: cereceda l. Am J Surg Pathol. 2016 Mar;40(3):378-85. doi: 10.1097/PAS.0000000000000571. Am J Surg Pathol. 2016. PMID: 26574847
29 results